InspireMD Announces C-GUARDIANS Trial Results in JACC

InspireMD's C-GUARDIANS trial results, published in JACC, demonstrate the safety and efficacy of the CGuard Prime carotid stent system in patients with asymptomatic carotid stenosis. The trial showed low rates of disabling stroke or myocardial infarction through 30 days and low ipsilateral stroke rates through one year, with no unexpected device-related adverse events reported. This makes the CGuard Prime the only carotid stenting system to achieve these results.